Sign In
Buy BSX
$48.85
+1.16 (+2.43%)
At Close: Jun 04, 2026
5 Analysts Have This to Say About Boston Scientific
01:15pm, Thursday, 28'th Apr 2022 Benzinga
Boston Scientific (NYSE:BSX) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
2
1
2
0
0
Last 3
Boston Scientific (BSX) Q1 2022 Earnings Call Transcript
06:30pm, Wednesday, 27'th Apr 2022 The Motley Fool
BSX earnings call for the period ending March 31, 2022.
Boston Scientific (BSX) Q1 Earnings Top, 2022 Revenue View Up
03:37pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
Boston Scientific (BSX) registers a year-over-year improvement in organic sales, indicating a strong rebound in the legacy business from the pandemic mayhem.
Boston Scientific (BSX) Q1 Earnings Top, 2022 Revenue View Up
01:03pm, Wednesday, 27'th Apr 2022
Boston Scientific (BSX) registers a year-over-year improvement in organic sales, indicating a strong rebound in the legacy business from the pandemic mayhem.
Boston Scientific Corporation (BSX) CEO Mike Mahoney on Q1 2022 Results - Earnings Call Transcript
11:50am, Wednesday, 27'th Apr 2022
Boston Scientific Corporation (NYSE:BSX ) Q1 2022 Earnings Conference Call April 27, 2022 8:00 AM ET Company Participants Lauren Tengler - Vice President, Investor Relations Mike Mahoney - Chairman &
Boston Scientific (BSX) Tops Q1 Earnings and Revenue Estimates
11:45am, Wednesday, 27'th Apr 2022 Zacks Investment Research
Boston Scientific (BSX) delivered earnings and revenue surprises of 2.63% and 2.45%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Boston Scientific Jumps On Upbeat Q2, FY22 Guidance
09:47am, Wednesday, 27'th Apr 2022
Boston Scientific Corp (NYSE: BSX) generated net sales of $3.026 billion in Q1 FY22, beating the Wall Street estimate of $2.95 billion. Sales increased 10% Y/Y on a reported basis, 12.6% on an opera
Boston Scientific (BSX) Tops Q1 Earnings and Revenue Estimates
09:02am, Wednesday, 27'th Apr 2022
Boston Scientific (BSX) delivered earnings and revenue surprises of 2.63% and 2.45%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Boston Scientific tops estimates for Q1, sending shares up 3.3% premarket
06:47am, Wednesday, 27'th Apr 2022
Boston Scientific Corp. shares BSX, -4.46% rose 3.3% premarket Wednesday, after the medical device maker reported lower earnings for the first quarter than a year ago but still beat consensus estimate
What To Expect From Boston Scientific Stock Following Q1 Earnings?
09:30am, Tuesday, 26'th Apr 2022
Revenues expected to be slightly above the consensus estimates Trefis estimates Boston Scientific's Q1 2022 revenues to be around $3.0 billion, slightly above the $2.9 billion consensus estimate.
Final Trades: FCX, BSX, UNH & MO
06:11pm, Friday, 22'nd Apr 2022
The final trades of the week. With CNBC's Melissa Lee and the Fast Money traders, Tim Seymour, Brian Kelly, Jeff Mills and Adam Parker.
Goldman Sachs And 3 Other Stocks Insiders Are Selling
12:55pm, Friday, 22'nd Apr 2022 Benzinga
Although gold futures traded lower this morning on Friday, there were a few notable insider trades.
When insiders sell shares, it indicates their concern in the company’s prospects or that they view
Boston Scientific (BSX) Reports Next Week: Wall Street Expects Earnings Growth
07:01pm, Wednesday, 20'th Apr 2022 Zacks Investment Research
Boston Scientific (BSX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in Store for Boston Scientific (BSX) in Q1 Earnings?
03:00pm, Wednesday, 20'th Apr 2022 Zacks Investment Research
Given an innovative pipeline, expansion into faster growth markets, globalization efforts and enhanced digital capabilities, Boston Scientific (BSX) is well-positioned to register strong first quarter
What's in Store for Boston Scientific (BSX) in Q1 Earnings?
12:02pm, Wednesday, 20'th Apr 2022
Given an innovative pipeline, expansion into faster growth markets, globalization efforts and enhanced digital capabilities, Boston Scientific (BSX) is well-positioned to register strong first quarter
